PTC Therapeutics, Inc. (PTCT) Financials

PTCT Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 3.3 billion 3.4 billion
March 31, 2026 2.9 billion 3.0 billion
Dec. 31, 2025 2.9 billion 3.1 billion
Sept. 30, 2025 2.6 billion 2.8 billion

PTCT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 122.0 million 23.3 million
March 31, 2026 -60.4 million 23.4 million
Dec. 31, 2025 -71.6 million 18.5 million
Sept. 30, 2025 -322.6 million 19.4 million

PTCT Net Income

No data available :(

PTCT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 2.2 billion 535.5 million 105.5 million
March 31, 2026 1.9 billion - 108.2 million
Dec. 31, 2025 1.9 billion 2.0 billion 112.1 million
Sept. 30, 2025 1.7 billion - 123.8 million

PTCT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 92.0 million
March 31, 2026 82.5 million
Dec. 31, 2025 80.7 million
Sept. 30, 2025 87.1 million

PTCT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 7.1 million 99.2 million 80.6 million -
March 31, 2026 1.4 million 100.9 million 86.2 million -
Dec. 31, 2025 37.3 million 133.1 million 100.5 million -
Sept. 30, 2025 256.3 million 100.2 million 84.0 million -

PTCT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 360.5 million 19.9 million
March 31, 2026 272.6 million 28.0 million
Dec. 31, 2025 164.7 million 16.3 million
Sept. 30, 2025 211.0 million 115.9 million

PTCT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PTCT

Price: $71.70

52 week price:
43.18
90.87

Earnings Per Share: -0.67 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 588300

Ebitda: -20.6 million

Market Capitalization: 5.9 billion

Links: